As the medical cannabis industry continues to demonstrate significant growth and economic potential in the UK, it's crucial to keep a close eye on key players poised to make a substantial impact in this burgeoning sector.
Maple Tree Consultants, industry-leading experts in the UK's cannabis sector, have identified Dalgety as a company to learn from. In this blog post, we'll explore what makes Dalgety one to watch moving forward.
Dalgety: A Key Player in the UK Medical Cannabis Marketplace
Dalgety, founded in 2016, has been making waves in the medical cannabis industry with its state-of-the-art secure UK-based facility, designed and built to meet the highest pharmaceutical standards. With a strong commitment to consistent product quality, Dalgety invests heavily in research and development to ensure its prescription-quality products remain at the forefront of the market.
Using an innovative AI management system, Dalgety's team carefully controls and monitors each stage of production, from seed to harvest. Expert horticulturists supervise this process, making certain that each plant is cultivated in carefully regulated conditions with ideal lighting, hydration, and temperature uniformly spread across the entire 3,000 square metre indoor cultivation facility. A computer-controlled hydroponic environment maintains positive pressure throughout their growing and drying rooms.
Notably, board members at Dalgety include two former representatives from the government and the police force, highlighting Dalgety's commitment to establishing cannabis-based medicines as a mainstream and economically viable solution for managing various conditions.
Former Home Secretary, Rt Hon Jacqui Smith, sits on the board of directors, lending her expertise to the company. With an interesting history in terms of cannabis legislation, during her tenure from 2007 to 2009, cannabis was reclassified from a class C to a class B substance - a decision then Home Secretary Smith based on concerns around young people accessing high-strength skunk, which received significant criticism. An opinion she later revised, Smith's current work with Dalgety indicates her confidence in the economic and medical potential for cannabis. Jane Sawyers, a former Chief Constable and executive lead for drugs investigation and enforcement also sits on the board.
Quality & Innovation Secures Licencing Milestone
In April, Dalgety secured Home Office approval to cultivate, process, and pack medicinal cannabis for sale to the pharmaceutical market, allowing the company to manufacture EU-GMP grade high-THC medicinal cannabis from its facility.
This exciting milestone in the development of the sector has the potential to ensure patients in the UK have access to high-quality and reliable sources of medical cannabis, free from the supply chain obstructions that non-UK producers currently face.
What's Next for Dalgety and Other UK-Based Sector Businesses?
Looking forward, Dalgety plans to complete the cultivation of their first commercial crop and continue expanding their team. The company is also focusing on a second round of investment to support these team additions and the further development of their indoor growing facility.
As the medical cannabis industry in the UK continues to show remarkable growth and exciting economic potential, now is the perfect time for businesses to position themselves as key players in this burgeoning sector. With Maple Tree Consultants as a trusted partner, we're here to support businesses seeking to achieve sustainable growth and capitalise on the opportunities arising from this expanding market.
Our extensive knowledge and experience in the industry enable us to provide expert support and guidance tailored to your unique needs. Don't miss out on the chance to be a part of the UK's thriving medical cannabis market and contribute to the economic prosperity of this innovative sector.
Reach out to Maple Tree Consultants today to learn more about how we can help your business flourish and succeed in the rapidly evolving landscape of the UK medical cannabis industry.